Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin

scientific article published on 15 November 2018

Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/ANTIBIOTICS7040100
P932PMC publication ID6316254
P698PubMed publication ID30445704

P50authorNaveed Ahmed KhanQ61081517
Ruqaiyyah SiddiquiQ86651636
P2093author name stringMuhammad Raza Shah
Ayaz Anwar
Dania Ahmed
Abdulkader Masri
P2860cites workLysates of Locusta migratoria brain exhibit potent broad-spectrum antibacterial activity.Q52692229
A Nanocomposite Hydrogel with Potent and Broad-Spectrum Antibacterial Activity.Q53696156
Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli.Q54400495
Bactericidal assessment of nano-silver on emerging and re-emerging human pathogensQ88594658
Multidrug resistance in bacteriaQ22255652
Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factorsQ24550738
Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitorsQ26778608
The bactericidal effect of silver nanoparticlesQ29615514
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnologyQ29617209
Disease ecology, health and the environment: a framework to account for ecological and socio-economic drivers in the control of neglected tropical diseases.Q30061728
Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteriaQ33978543
Growth factor delivery-based tissue engineering: general approaches and a review of recent developmentsQ34548765
Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coliQ34623923
Silver nanoparticles as a new generation of antimicrobials.Q34852512
Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to ActivityQ35964477
Resistance to antibiotics: are we in the post-antibiotic era?Q36282569
Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive powerQ36963701
Microbial drug discovery: 80 years of progressQ37365189
What is MRSA?Q37625602
Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humansQ37867193
Nanoparticles as drug delivery systems.Q38067256
Application of nanodiagnostics in point-of-care tests for infectious diseasesQ38652389
Current applications of nanoparticles in infectious diseases.Q38698207
A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicityQ39001413
Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part 3: cephalosporinsQ39629364
Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana).Q40506281
Bacillus cereus and its food poisoning toxinsQ41685213
Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteriaQ42573644
Synthesis of 4-(dimethylamino)pyridine propylthioacetate coated gold nanoparticles and their antibacterial and photophysical activity.Q47697037
Revelation of susceptibility differences due to Hg(II) accumulation in Streptococcus pyogenes against CX-AgNPs and Cefixime by atomic force microscopyQ47720373
Cationic Acrylate Oligomers Comprising Amino Acid Mimic Moieties Demonstrate Improved Antibacterial Killing Efficiency.Q48644547
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P921main subjectnanoparticleQ61231
P577publication date2018-11-15
P1433published inAntibiotics (Basel, Switzerland)Q27725829
P1476titleSilver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin
P478volume7

Reverse relations

cites work (P2860)
Q90633118Antibacterial Effects of Quinazolin-4(3H)-One Functionalized-Conjugated Silver Nanoparticles
Q89552234Bacteria Exposed to Silver Nanoparticles Synthesized by Laser Ablation in Water: Modelling E. coli Growth and Inactivation
Q91329690Gut bacteria of Cuora amboinensis (turtle) produce broad-spectrum antibacterial molecules
Q90950844Surface Modification by Media Organics Reduces the Bacterio-toxicity of Cupric Oxide Nanoparticle against Escherichia coli
Q91964640The Use of Nanomedicine for Targeted Therapy against Bacterial Infections

Search more.